Simpson Reps Daiichi Sankyo In $805M Plexxikon Buy

By Pete Brush · March 1, 2011, 4:05 PM EST

Daiichi Sankyo Co. Ltd. said Tuesday it will pay $805 million to buy Plexxikon Inc., a privately held pharmaceutical company based in Berkeley, Calif., with a promising late-stage treatment for metastatic...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login